TD Asset Management
TECX

TD Asset Management’s Tectonic Therapeutic TECX Stock Holding History

TD Asset Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,400
Closed -$631K – 1333
2026
Q1 		$631K Buy
+20,400
New +$502K ﹤0.01% 1151
2020
Q4 		– Sell
-1,393
Closed -$218K – 1480
2020
Q3 		$218K Hold
1,393
– – ﹤0.01% 1332
2020
Q2 		$292K Hold
1,393
– – ﹤0.01% 1267
2020
Q1 		$260K Buy
1,393
+225
+19% +$53K ﹤0.01% 1286
2019
Q4 		$282K Sell
1,168
-266
-19% -$51.3K ﹤0.01% 1327
2019
Q3 		$243K Buy
1,434
+225
+19% +$50.9K ﹤0.01% 1282
2019
Q2 		$236K Sell
1,209
-50
-4% -$10.8K ﹤0.01% 1280
2019
Q1 		$333K Sell
1,259
-200
-14% -$36.6K ﹤0.01% 1245
2018
Q4 		$291K Hold
1,459
– – ﹤0.01% 1307
2018
Q3 		$908K Buy
1,459
+825
+130% +$366K ﹤0.01% 1181
2018
Q2 		$217K Buy
+634
New +$229K ﹤0.01% 1380

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

TD Asset Management's TECX Position: Q2 2026 in Review

TD Asset Management sold out of Tectonic Therapeutic (TECX) in Q2 2026, closing a stake of 20,400 shares — an estimated $631K sold.

TD Asset Management first reported a position in TECX in Q2 2018 and held it in 11 quarters. The position peaked at $908K in Q3 2018. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • TD Asset Management reported no remaining Tectonic Therapeutic position as of Q2 2026 after selling out during the quarter.
  • TD Asset Management sold 20,400 Tectonic Therapeutic shares in Q2 2026, an estimated $631K.
  • TD Asset Management first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 11 quarters.
  • TD Asset Management's Tectonic Therapeutic position peaked at $908K in Q3 2018.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.